Viela Bio Shareholders Sue AstraZeneca In Del. After $3B Sale
Former Viela Bio Inc. stockholders have sued ex-company parent AstraZeneca PLC, its UK Ltd. affiliate and key figures of both companies in Delaware's Court of Chancery over a purportedly underpriced $3...To view the full article, register now.
Already a subscriber? Click here to view full article